Endocrinology: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapyZeev Blumenfeld, Nissim Haim, I. Avivi et al.|Human Reproduction|1996Cited by 266
Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphomaZeev Blumenfeld, Eldad J. Dann, Irith Avivi et al.|Fertility and Sterility|2007Cited by 179
Fertility after treatment for Hodgkin's diseaseZeev Blumenfeld, Jacob M. Rowe, Eldad J. Dann et al.|Annals of Oncology|2002Cited by 153
Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphomaEldad J. Dann, Zeev Blumenfeld, Menachem Ben Shahar et al.|Human Reproduction|2005Cited by 79
A 10‐year experience with treatment of high and standard risk Hodgkin disease: Six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preservedEldad J. Dann, Ron Epelbaum, Zeev Blumenfeld et al.|American Journal of Hematology|2011Cited by 34